Strides Pharma Science Limited informed the Board of Directors of the Company in their meeting held on January 8, 2020, approved the appointment of Dr. R Ananthanarayanan as Chief Executive Officer & Managing Director of the Company effective January 9, 2020, for a period of 5 years, subject To Approve the Members of the Company. Further, he is also appointed as Key Managerial Personnel of the Company effective January 9, 2020. The company also announced the re-designation of Mr. Arun Kumar as Executive Director effective January 9, 2020.

Until recently, Ananth was the Global Chief Operating Officer at Cipla Limited, where he was responsible for the company's generics business in regulated markets and branded generics in emerging markets.